Business of Bioanalysis: The Impact of Pharma Mergers on CROs

Watch Dr. Afshin Safavi, BioAgilytix Global CSO discuss how mergers and acquisitions have impacted CROs and drug development as part of the “Business of Bioanalysis” panel hosted by Bioanalysis Zone.

*Video Produced by Bioanalysis Zone

Share This